Anlon Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01025
  • NSEID: AHCL
  • BSEID: 544497
INR
25.14
0.2 (0.8%)
BSENSE

Nov 20

BSE+NSE Vol: 52.72 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kopran
NGL Fine Chem
Anlon Healthcare
Sigachi Indust.
Bharat Parenter.
Jagsonpal Pharma
Amrutanjan Healt
Bafna Pharma.
Bajaj Healthcare
Fermenta Biotec.
Accent Microcell
Why is Anlon Healthcare Ltd ?
1
With a growth in Net Sales of 15.8%, the company declared Very Positive results in Sep 26
  • NET SALES(Q) Highest at Rs 105.61 cr
  • PBDIT(Q) Highest at Rs 25.24 cr.
  • PBT LESS OI(Q) Highest at Rs 23.42 cr.
2
Stock is technically in a Mildly Bullish range
  • A key technical factor - KST has been Bullish since 02 Nov 2026
3
With ROE of 13.2, it has a Very Expensive valuation with a 6.4 Price to Book Value
  • Over the past year, while the stock has generated a return of 63.04%, its profits have risen by 36%
4
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -1.59% over the previous quarter and collectively hold 1.3% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Market Beating Performance
  • The stock has generated a return of 63.04% in the last 1 year, much higher than market (BSE500) returns of 0.37%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Anlon Healthcare should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Anlon Healthcare for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Anlon Healthcare
63.04%
0.57
110.44%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
46.70%
EBIT Growth (5y)
47.11%
EBIT to Interest (avg)
10.26
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
0.86
Tax Ratio
34.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.30%
ROCE (avg)
9.07%
ROE (avg)
19.87%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
38
Industry P/E
40
Price to Book Value
6.40
EV to EBIT
29.85
EV to EBITDA
28.77
EV to Capital Employed
5.49
EV to Sales
7.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.41%
ROE (Latest)
13.25%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

27What is working for the Company
NET SALES(Q)

Highest at Rs 105.61 cr

PBDIT(Q)

Highest at Rs 25.24 cr.

PBT LESS OI(Q)

Highest at Rs 23.42 cr.

PAT(Q)

Highest at Rs 13.37 cr.

EPS(Q)

Highest at Rs 0.25

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Anlon Healthcare
Net Sales - Quarterly
At Rs 105.61 cr has Grown at 86.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 56.56 Cr
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 23.42 cr has Grown at 84.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 12.72 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 13.37 cr has Grown at 69.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 7.91 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 105.61 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 25.24 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 23.42 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 13.37 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 0.25
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)